Literature DB >> 11935086

Pathology and pathogenesis of hepatocellular carcinoma.

C Röcken1, S Carl-McGrath.   

Abstract

Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver and among the most common cancers worldwide. The distribution pattern of HCC shows geographical variation and its pathogenesis is multifactorial. Environmental, infectious, nutritional, metabolic, and endocrine factors contribute directly or indirectly to hepatocarcinogenesis. The synchronous occurrence of different risk factors, such as chronic viral hepatitis B and C, aflatoxin exposure, alcohol consumption or iron overload, in a single patient or patient population further increases the risk. HCC is commonly associated with chronic hepatitis and liver cirrhosis. Different genes have been implicated in the pathogenesis of HCC, and may be divided into four major groups: genes regulating DNA damage response; genes involved in cell cycle control; genes involved in growth inhibition and apoptosis, and genes responsible for cell-cell interaction and signal transduction. Hepatocarcinogenesis is mediated by loss of heterozygosity, somatic mutation, de novo methylation, and/or functional inactivation. As yet, there is no evidence for an ordered sequence of genomic events leading to hepatocarcinogenesis. The pattern of genomic alterations shows great variability, often between two different HCCs from a single patient. HCC evolves from precancerous lesions, and well-differentiated HCC further progresses to a less differentiated form. However, there is still great need for the definition of objective morphological, phenotypic and genetic markers for the progression of HCC. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11935086     DOI: 10.1159/000050693

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  24 in total

Review 1.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells.

Authors:  Zhi-Su Liu; Sheng-Li Tang; Zhong-Li Ai
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

3.  Anticancer mechanisms of Strobilanthes crispa Blume hexane extract on liver and breast cancer cell lines.

Authors:  Rhun Yian Koh; Foong Ping Lim; Leslie Siing Yie Ling; Catherine Pei Ling Ng; Siew Foong Liew; Mei Yeng Yew; Yee Lian Tiong; Anna Pick Kiong Ling; Soi Moi Chye; Khuen Yen Ng
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

4.  Usefulness of F-18 FDG PET/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular Carcinoma.

Authors:  Sung Hoon Kim; Kyoung Sook Won; Byung Wook Choi; Il Jo; Seok Kil Zeon; Woo Jin Chung; Jung Hyeok Kwon
Journal:  Nucl Med Mol Imaging       Date:  2012-04-28

Review 5.  Cancer burden and trends in the Asian Pacific Rim region.

Authors:  Binh H Yang; D Maxwell Parkin; Lin Cai; Zuo Feng Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2004 Apr-Jun

6.  FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma.

Authors:  Tatsuya Higashi; Etsuro Hatano; Iwao Ikai; Ryuichi Nishii; Yuji Nakamoto; Koichi Ishizu; Tsuyoshi Suga; Hidekazu Kawashima; Kaori Togashi; Satoru Seo; Koji Kitamura; Yasutsugu Takada; Yasuji Takada; Shinji Uemoto; Shinji Kamimoto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-17       Impact factor: 9.236

7.  Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2.

Authors:  Sarveswaran Sivalokanathan; Marati Radhakrishnan Vijayababu; Maruthaiveeran Periyasamy Balasubramanian
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 8.  Liver transplantation for hepatocellular carcinoma.

Authors:  Jerome Byam; John Renz; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2013-02       Impact factor: 7.293

9.  Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.

Authors:  Weihua Qiu; Donald David; Bingsen Zhou; Peiguo G Chu; Bohe Zhang; Mengchao Wu; Jiacheng Xiao; Tianquan Han; Zhenggang Zhu; Tianxiang Wang; Xiyong Liu; Richard Lopez; Paul Frankel; Ambrose Jong; Yun Yen
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.

Authors:  Jeronimo A Nogueira; Suzane K Ono-Nita; Marcelo E Nita; Marcelo M T de Souza; Eliane P do Carmo; Evandro S Mello; Cristovan Scapulatempo; Denise C Paranaguá-Vezozzo; Flair J Carrilho; Venancio A F Alves
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.